Diagnosis typically relies on the detection of extremely low or undetectable serum ceruloplasmin levels, along with clinical, biochemical, and radiological evidence of iron overload in target organs, and is confirmed by genetic testing to identify mutations in the CP gene. This evidence concerns the gene CP and Tangier disease.